Science

The technology, on the record

Every paper, patent, trial and regulatory notice behind the stem cell technology our programs use, each linked to its original source. Records are listed as they are, with no efficacy claims.

Research record

The stem cell science behind the network, on the public record

Umbilical cord lining stem cell research by Prof. Phan Toan Thang's team in Singapore and CellResearch Corporation (CRC), listed from the original papers, patents, trial registries and regulatory notices. Every item links to its source.

89PubMed papersTopic-limited search · 37 key papers listed
69Granted patents17 jurisdictions
14Patent families8 with grants
1Registered US trialPhase 1 completed · FDA IND
2004Root patent priority16 Aug 2004

As of 2026-11-16 · Sources: PubMed (NCBI), Google Patents, ClinicalTrials.gov, CRC website, press · Patent status as shown on Google Patents

From research to Cellumium
1 · ResearchCord lining stem cell research

Team of Assoc. Prof. Phan Toan Thang, Department of Surgery, National University of Singapore. Public papers, patents and trials.

Public record
2 · TechnologyCellResearch Corp (2002, Singapore)

Co-founded by Prof. Phan, who serves as founding director and Group CSO. Holds the cord lining stem cell patents.

Public record
3 · ProgramCellumigen stem cell program

Cellumigen, our founding partner, runs stem cell programs based on this line of technology at clinics in Hanoi and Johor Bahru.

Partner-provided
4 · NetworkCellumium

Opens the way to programs through a shared membership tier and a public ledger.

Planned

Key dates

CellResearch Corporation founded in SingaporeCRC ↗
Priority date of the root patent on isolating cord lining stem/progenitor cells (PCT/SG2005/000174)Google Patents ↗
Paper on isolating and characterizing subamnion MSCs (Stem Cells and Development)PubMed ↗
Review of cord lining epithelial and mesenchymal stem cells (Cell Transplantation)PubMed ↗
FDA IND cleared for diabetic foot ulcers (not an approval)PR Newswire ↗
US phase 1 trial starts (University of Colorado, NCT04104451)ClinicalTrials.gov ↗
UK MHRA Innovation Passport (development designation, not an approval)PharmTech ↗
Korean patent granted, KR102491558B1 (isolating cord lining MSCs)Google Patents ↗
Phase 1 safety results published (Biomedicines)PubMed ↗
All records

Company

Prof. Phan Toan Thang's current roles

Founding director and Group Chief Scientific Officer of CRC. Associate Professor of Surgery at the National University of Singapore and lead of a wound healing and stem cell research group.

Patents · Family F09

A mesenchymal stem cell storing or transport formulation and methods of making and using the same

AU2020364930B2 · AU · Granted · Active
Patents · Family F14

Use of conditioned medium of cord lining mesenchymal stem cells for healing and/or preventing the formation and/or recurrence of a wound or a damaged skin area

US20260199401A1 · US · Application · Pending
Patents · Family F13

Use of conditioned medium derived from cultivation of mesenchymal stem cells of the umbilical cord for inducing, stimulating and promoting hair growth and regeneration

US20260191766A1 · US · Application · Pending
Patents · Family F08

Methods for inducing or improving the wound healing properties of mesenchymal stem cells (machine-translated)

JP7876213B2 · JP · Granted · Active
Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

AU2024200348B2 · AU · Granted · Active
Patents · Family F09

Mesenchymal stem cell storage or transport preparation, and method for preparing and using the same (machine-translated)

JP7861268B2 · JP · Granted · Active
Patents · Family F11

Method for producing induced pluripotent stem cells, induced pluripotent stem cells, and method for using induced pluripotent stem cells (machine-translated)

JP7829191B2 · JP · Granted · Active
Patents · Family F10

Methods for assessing the wound-healing efficacy of mesenchymal stem cell populations, and related methods (machine-translated)

CN114829942B · CN · Granted · Active
Patents · Family F06

Method for transporting mesenchymal stem cells with a transport solution and method for administering stem cells to wounds (machine-translated)

JP7804359B2 · JP · Granted · Active
Papers · Review · Systematic review

Enhancing the therapeutic efficacy of umbilical cord-derived mesenchymal stem cells (UC-MSCs) in wound healing: a systematic review.

Cell and tissue banking · Reza HM, ..., Phan TT (last)
Patents · Family F04

Methods for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord and for preparing ... (machine-translated)

BR112019005652B1 · BR · Granted · Granted (status not shown)
Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

NZ749769B2 · NZ · Granted · Granted (status not shown)
Patents · Family F04

Method for isolating mesenchymal stem cells from umbilical cord membrane using cell culture medium

IL307825B2 · IL · Granted · Granted (status not shown)
Patents · Family F08

Method of inducing or improving wound healing properties of mesenchymal stem cells

US12460178B2 · US · Granted · Active
Patents · Family F13

Use of a conditioned medium derived from culture of mesenchymal stem cells of the umbilical cord for inducing, stimulating and promoting hair growth and regeneration (machine-translated)

KR20250152054A · KR · Application · Pending
Patents · Family F14

Use of conditioned medium of umbilical cord-derived mesenchymal stem cells for treating and/or preventing ... wound or damaged skin area (machine-translated)

KR20250152058A · KR · Application · Pending
Patents · Family F10

Method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population

US12449413B2 · US · Granted · Active
Patents · Family F14

Use of conditioned medium of cord lining mesenchymal stem cells for healing and/or preventing the formation and/or recurrence of a wound or a damaged skin area

EP4630022A1 · EP · Application · Pending
Patents · Family F06

A method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds

AU2019253009B2 · AU · Granted · Active
Patents · Family F13

Use of conditioned medium derived from cultivation of mesenchymal stem cells of the umbilical cord for inducing, stimulating and promoting hair growth and regeneration

EP4619012A1 · EP · Application · Pending
Patents · Family F04

Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord

US20250290043A1 · US · Application · Pending
Patents · Family F04

Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord

US12344861B2 · US · Granted · Active
Patents · Family F08

A method of inducing or improving wound healing properties of mesenchymal stem cells

AU2019250653B2 · AU · Granted · Active
Patents · Family F12

A method of differentiating an induced pluripotent stem cell into a retinal pigment epithelial cell, a retinal pigment epithelial cell and methods of using the retinal pigment epithelial cell

US20250197803A1 · US · Application · Abandoned
Patents · Family F08

A method of inducing or improving wound healing properties of mesenchymal stem cells

TWI882956B · TW · Granted · Granted (status not shown)
Patents · Family F08

A method for inducing or improving the wound healing properties of mesenchymal stem cells (machine-translated)

CN112262211B · CN · Granted · Active
Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

HK40004787B · HK · Granted · Granted (status not shown)
Patents · Family F10

Methods for assessing the wound healing efficacy of mesenchymal stem cell populations and related methods (machine-translated)

JP7650085B2 · JP · Granted · Active
Patents · Family F04

A method for isolating mesenchymal stem cells from umbilical cord amniotic membrane using cell culture medium (machine-translated)

CN109804063B · CN · Granted · Active
Papers · Skin & cosmetics · In vitro

Red Deer Umbilical Cord Lining Mesenchymal Stem Cell-Conditioned Media Stimulates Fibroblast Elastin and Hyaluronic Acid Production to Improve Eyelid Aesthetics.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · Lim IJ, ..., Phan TT (last)

Authors include CRC staff (conflict of interest declared).

Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

EP3523421B1 · EP · Granted · Active
Trials · Skin around diabetic foot ulcers

Addressing the Peri-Wound Intact Skin of Hard-To-Heal Diabetic Foot Ulcers With Topical Red Deer Conditioned Media (PTT-6™) Skin Conditioner: A Case Series

Case series (not a registered trial)

Case series on a topical product made from red deer (not human) cord lining stem cell conditioned media (PTT-6). No control group. CRC supplied the product (conflict of interest declared).

Patents · Family F08

Methods for inducing or improving wound healing properties of mesenchymal stem cells (machine-translated)

JP7541730B2 · JP · Granted · Active
Patents · Family F14

Use of conditioned medium of cord lining mesenchymal stem cells for healing and/or preventing the formation and/or recurrence of a wound or a damaged skin area

WO2024123237A1 · WO · Application · Lapsed
Patents · Family F14

Use of conditioned medium of cord lining mesenchymal stem cells for healing and/or preventing the formation and/or recurrence of a wound or a damaged skin area

CA3276013A1 · CA · Application · Pending
Patents · Family F06

Method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds

US11998569B2 · US · Granted · Active
Trials · Diabetic foot ulcer

Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers

NCT04104451 results paper · Phase 1

Published results of the phase 1 study run under an FDA IND. No serious adverse events or anti-HLA antibodies were reported in the 9 participants who completed it. A small uncontrolled safety study, not evidence of efficacy. CRC co-founders are authors (conflict of interest declared).

Patents · Family F13

Use of conditioned medium derived from cultivation of mesenchymal stem cells of the umbilical cord for inducing, stimulating and promoting hair growth and regeneration

WO2024107102A1 · WO · Application · Lapsed
Patents · Family F13

Use of conditioned medium derived from cultivation of mesenchymal stem cells of the umbilical cord for inducing, stimulating and promoting hair growth and regeneration

WO2024107122A1 · WO · Application · Lapsed
Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

MY202675A · MY · Granted · Granted (status not shown)
Patents · Family F04

Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord

TWI836505B · TW · Granted · Granted (status not shown)
Patents · Family F06

Methods of transporting mesenchymal stem cells by means of a transport solution and methods of administering stem cells to wounds (machine-translated)

JP7446619B2 · JP · Granted · Active
Patents · Family F09

Mesenchymal stem cell storage or transport preparations and preparation and use methods thereof (machine-translated)

CN114867347B · CN · Granted · Active
Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

IL264197B2 · IL · Granted · Granted (status not shown)
Papers · Diabetic foot & chronic wounds · Human · phase 1 trial

Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers.

Biomedicines · Low Wang CC, ..., Phan TT (9/11)

Authors include CRC staff (conflict of interest declared).

Papers · Diabetic foot & chronic wounds · Human · observational

Addressing the Peri-Wound Intact Skin of Hard-To-Heal Diabetic Foot Ulcers With Topical Red Deer Conditioned Media (PTT-6TM) Skin Conditioner: A Case Series on Clinical Efficacy.

Health science reports · Leow K, ..., Phan TT (10/11)

Authors include CRC staff (conflict of interest declared).

Patents · Family F04

Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord

US11821006B2 · US · Granted · Active
Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

AU2017339344B2 · AU · Granted · Active
Patents · Family F11

A method of generating an induced pluripotent stem cell, an induced pluripotent stem cell and methods of using the induced pluripotent stem cell

US20230285470A1 · US · Application · Pending
Patents · Family F12

A method of differentiating an induced pluripotent stem cell into a retinal pigment epithelial cell, a retinal pigment epithelial cell and methods of using the retinal pigment epithelial cell

WO2023146477A2 · WO · Application · Lapsed
Patents · Family F04

Method for isolating mesenchymal stem cells from umbilical amniotic membrane using cell culture medium (machine-translated)

JP7262775B2 · JP · Granted · Active
Patents · Family F04

Method for isolating mesenchymal stem cells from umbilical cord amniotic membrane using cell culture medium (machine-translated)

KR102491558B1 · KR · Granted · Active
Papers · Skin & cosmetics · In vitro

Improvement in Skin Elasticity Using Red Deer Umbilical Cord Lining Mesenchymal Stem Cell Conditioned Media.

Journal of drugs in dermatology : JDD · Ong C, ..., Phan TT (last)

Authors include CRC staff (conflict of interest declared).

Patents · Family F10

A method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population

ZA202203195B · ZA · Granted · Granted (status not shown)
Company

Scientific advisory board formed

Diabetic foot specialists David Armstrong and Andrew Boulton, and Apligraf inventor Paul Kemp, joined in 2022.

Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

SA519401455B1 · SA · Granted · Granted (status not shown)
Company

Adalvo partnership

Pharmaceutical company Adalvo announced the phase 1 results, naming CRC as a partner. Terms were not disclosed.

Patents · Family F04

Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord

TWI773693B · TW · Granted · Granted (status not shown)
Patents · Family F09

Mesenchymal stem cell storage or transport formulations and methods of making and using the same (machine-translated)

KR20220108763A · KR · Application · Pending
Patents · Family F06

Method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds

US11400119B2 · US · Granted · Active
Patents · Family F10

Methods for evaluating wound healing efficacy of mesenchymal stem cells and related methods (machine-translated)

KR20220078637A · KR · Application · Pending
Regulatory

EU EMA SME status

A company status that reduces regulatory fees. Not a product approval. Based on company press releases.

Patents · Family F11

A method of generating an induced pluripotent stem cell, an induced pluripotent stem cell and methods of using the induced pluripotent stem cell

WO2022019832A1 · WO · Application · Lapsed
Papers · Wound & burn healing · In vitro & animal

Human Umbilical Cord Lining-Derived Epithelial Cells: A Potential Source of Non-Native Epithelial Cells That Accelerate Healing in a Porcine Cutaneous Wound Model.

International journal of molecular sciences · Kua JEH, ..., Phan TT (8/9)
Papers · Skin & cosmetics · Methods (human tissue, ex vivo)

Sensitive ex vivo human skin transdermal assay testing method with mass spectrometric analysis for cosmetics application.

Journal of cosmetic dermatology · Tan TY, ..., Phan TT (8/9)
Papers · Other · Animal

Intraperitoneally Delivered Umbilical Cord Lining Mesenchymal Stromal Cells Improve Survival and Kidney Function in Murine Lupus via Myeloid Pathway Targeting.

International journal of molecular sciences · Chua AWC, ..., Phan TT (11/12)
Patents · Family F02

Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom

US20210340497A1 · US · Application · Abandoned
Regulatory

UK MHRA Innovation Passport

Granted to CorLiCyte for diabetic foot ulcers under the UK's Innovative Licensing and Access Pathway (ILAP). A development-stage designation, not an approval.

Patents · Family F08

A method of inducing or improving wound healing properties of mesenchymal stem cells

ZA202005967B · ZA · Granted · Granted (status not shown)
Patents · Family F02

Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom

US11066645B2 · US · Granted · Active
Patents · Family F04

Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord

US10988736B2 · US · Granted · Active
Patents · Family F09

A mesenchymal stem cell storing or transport formulation and methods of making and using the same

WO2021071430A1 · WO · Application · Lapsed
Patents · Family F10

A method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population

WO2021071429A1 · WO · Application · Lapsed
Patents · Family F09

Mesenchymal stem cell storing or transport formulation and methods of making and using the same

US20210102171A1 · US · Application · Pending
Patents · Family F08

A method of inducing or improving wound healing properties of mesenchymal stem cells

EP3775163A1 · EP · Application · Pending
Patents · Family F08

Method for inducing or improving wound healing properties of mesenchymal stem cells (machine-translated)

KR20200143399A · KR · Application · Lapsed
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

US20200390820A1 · US · Application · Abandoned
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

US10780130B2 · US · Granted · Expired
Company

Cell manufacturing at University of Colorado ClinImmune (cGMP)

CorLiCyte master cell banks are produced under cGMP by ClinImmune Labs at the University of Colorado. The Singapore lab handles quality and biomarker testing.

Patents · Family F01

Method for isolating epithelial or mesenchymal stem/progenitor cells from the umbilical cord amniotic membrane (machine-translated)

BRPI0514387B1 · BR · Granted · Granted (status not shown)
Papers · Other · Animal

Safety Evaluation of Human Cord-Lining Epithelial Stem Cells Transplantation for Liver Regeneration in a Porcine Model.

Cell transplantation · Lim RHG, ..., Phan TT (last)
Papers · Other · Animal

Cord Lining Mesenchymal Stem Cells Have a Modest Positive Effect on Angiogenesis in Hindlimb Ischemia.

Frontiers in cell and developmental biology · Chua K, ..., Phan TT (4/6)
Trials · Diabetic foot ulcer

Phase 1, Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stem Cells (CorLiCyte®) to Heal Chronic Diabetic Foot Ulcers

NCT04104451 · Phase 1 · Completed

Single-site, open-label, dose-escalation safety study of cord lining MSCs (CorLiCyte) in chronic diabetic foot ulcers at the University of Colorado Anschutz. Completed in 2023.

Patents · Family F06

A method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds

WO2019199229A1 · WO · Application · Lapsed
Patents · Family F07

A method of transporting mesenchymal stem cells by means of a cell culture medium and a method of administering stem cells to wounds

WO2019199230A1 · WO · Application · Lapsed
Patents · Family F08

A method of inducing or improving wound healing properties of mesenchymal stem cells

WO2019199234A1 · WO · Application · Lapsed
Patents · Family F05

Use of an essentially pure mesenchymal stem cell population of the amniotic membrane of umbilical cord for generating a mammalian stem cell carrying a transgene

WO2019194751A1 · WO · Application · Lapsed
Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

ZA201900207B · ZA · Granted · Granted (status not shown)
Patents · Family F02

Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom

HK1194433B · HK · Granted · Granted (status not shown)
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

US10363275B2 · US · Granted · Active
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

US10322148B2 · US · Granted · Expired
Patents · Family F04

Isolation of mesenchymal stem cells from umbilical cord amniotic membrane using cell culture medium (machine-translated)

KR20190055790A · KR · Application · Granted (status not shown)
Company

CALECIM skincare distribution with Menarini Asia-Pacific

Distribution partnership covering China, Hong Kong, Thailand, Malaysia, the Philippines and Indonesia. Based on company press releases.

Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

SG11201900753VA · SG · Application · Published
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

CA2971062C · CA · Granted · Expired
Regulatory

FDA IND cleared

The Investigational New Drug application for CorLiCyte in diabetic foot ulcers was cleared. It allows human trials to begin and is not a marketing approval.

Patents · Family F02

Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom

EP1937326B1 · EP · Granted · Active
Patents · Family F02

Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom

US10066209B2 · US · Granted · Active
Patents · Family F04

A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

WO2018067071A1 · WO · Application · PCT phase ended
Patents · Family F02

Isolation and cultivation of stem/progenitor cells from umbilical cord amniotic membrane and uses of differentiated cells (machine-translated)

CN103555655B · CN · Granted · Expired
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

US9844571B2 · US · Granted · Expired
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

US9737568B2 · US · Granted · Expired
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

CA2577447C · CA · Granted · Expired
Patents · Family F03

A method of generating a mammalian stem cell carrying a transgene, a mammalian stem cell generated by the method and pharmaceuticals uses of the mammalian stem cell

WO2017105350A1 · WO · Application · Lapsed
Company

Cordlife partnership (since 2010) and 2016 investment

Began as a cord lining banking partnership. Cordlife invested a further S$8.4 million in February 2016.

Papers · Other · In vitro

Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human Cells.

Molecular therapy : the journal of the American Society of Gene Therapy · Sivalingam J, ..., Phan TT (8/10)
Patents · Family F01

Isolation of stem/progenitor cells from umbilical amniotic membrane (machine-translated)

JP5798546B2 · JP · Granted · Expired
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

US9085755B2 · US · Granted · Expired
Company

US collaborations: University of Colorado (2015), CariCord (2016)

Research and services agreement with the University of Colorado School of Medicine (2015), and expanded US cord tissue banking with CariCord (2016).

Patents · Family F02

Generating a mucin-producing cell from an umbilical cord amniotic membrane epithelial stem cell

US9040299B2 · US · Granted · Active
Patents · Family F01

Isolation of stem/progenitor cells from umbilical amniotic membrane (machine-translated)

JP5668208B2 · JP · Granted · Expired
Papers · Wound & burn healing · Animal

Preclinical Evaluation of Tegaderm™ Supported Nanofibrous Wound Matrix Dressing on Porcine Wound Healing Model.

Advances in wound care · Ong CT, ..., Phan TT (last)
Papers · Other · In vitro

Human Umbilical Cord Lining Cells as Novel Feeder Layer for Ex Vivo Cultivation of Limbal Epithelial Cells.

Investigative ophthalmology & visual science · Ang LP, ..., Phan TT (3/4)
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

EP1789534B1 · EP · Granted · Expired
Papers · Review · Review

Epithelial and mesenchymal stem cells from the umbilical cord lining membrane.

Cell transplantation · Lim IJ, Phan TT (Phan TT last)
Patents · Family F02

Application of isolation and culture of stem/progenitor cells and differentiated cells from umbilical cord amniotic membrane (machine-translated)

CN101330935B · CN · Granted · Expired
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord (machine-translated)

KR101322889B1 · KR · Granted · Expired
Patents · Family F01

Isolation of stem/progenitor cells from umbilical cord amnion (machine-translated)

CN101040042B · CN · Granted · Expired
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

EP2597149A1 · EP · Application · Abandoned
Papers · Cord stem cell isolation · In vitro & animal

Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.

Stem cells and development · Stubbendorff M, ..., Phan TT (4/13)
Papers · Cord stem cell isolation · In vitro

Metabolically functional hepatocyte-like cells from human umbilical cord lining epithelial cells.

Assay and drug development technologies · Cheong HH, ..., Phan TT (last)
Papers · Other · Animal

Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure.

Tissue engineering. Part A · Lilyanna S, ..., Phan TT (7/8)
Papers · Other · Animal

Grafts enriched with subamnion-cord-lining mesenchymal stem cell angiogenic spheroids induce post-ischemic myocardial revascularization and preserve cardiac function in failing rat hearts.

Stem cells and development · Martinez EC, ..., Phan TT (8/10)
Patents · Family F02

Skin equivalents derived from umbilical cord mesenchymal stem/progenitor cells and umbilical cord epithelial stem/progenitor cells

US8287854B2 · US · Granted · Expired
Patents · Family F01

Stem/progenitor cell recovery from amniotic membrane of umbilical cord (machine-translated)

RU2416638C2 · RU · Granted · Granted (status not shown)
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

AU2005273077B2 · AU · Granted · Expired
Papers · Cord stem cell isolation · In vitro & animal

Characterization of human umbilical cord lining-derived epithelial cells and transplantation potential.

Cell transplantation · Zhou Y, ..., Phan TT (9/12)
Papers · Cord stem cell isolation · In vitro & animal

Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.

Cell transplantation · Deuse T, ..., Phan TT (7/11)
Papers · Cord stem cell isolation · In vitro

Characterization of a novel umbilical cord lining cell with CD227 positivity and unique pattern of P63 expression and function.

Stem cell reviews and reports · Reza HM, ..., Phan TT (3/6)
Papers · Review · Review

Umbilical cord lining stem cells as a novel and promising source for ocular surface regeneration.

Stem cell reviews and reports · Reza HM, ..., Phan TT (4/5)
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

MY141772A · MY · Granted · Granted (status not shown)
Company

Technology transfer to Mekophar, Vietnam (MekoStem)

Vietnamese pharmaceutical company Mekophar licensed the cord lining stem cell extraction technology and set up the MekoStem stem cell bank (operating since 2009).

Papers · Cord stem cell isolation · In vitro

Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane.

Stem cells and development · Kita K, ..., Phan TT (3/5)
Papers · Cord stem cell isolation · In vitro

Cord lining progenitor cells: potential in vitro adipogenesis model.

International journal of obesity (2005) · Cheong HH, ..., Phan TT (3/4)
Papers · Other · In vitro & animal

Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells.

Molecular therapy : the journal of the American Society of Gene Therapy · Sivalingam J, ..., Phan TT (5/6)
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

NZ553695A · NZ · Granted · Granted (status not shown)
Patents · Family F01

Isolation, cultivation and uses of stem/progenitor cells

TWI312009B · TW · Granted · Granted (status not shown)
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

ZA200702144B · ZA · Granted · Granted (status not shown)
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

HK1104061B · HK · Granted · Granted (status not shown)
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

GB2432166B · GB · Granted · Expired
Papers · Cord stem cell isolation · In vitro

Common features of umbilical cord epithelial cells and epidermal keratinocytes.

Journal of dermatological science · Ruetze M, ..., Phan TT (5/9)
Papers · Wound & burn healing · In vitro

In vitro evaluation of fibrin mat and Tegaderm wound dressing for the delivery of keratinocytes--implications of their use to treat burns.

Burns : journal of the International Society for Burn Injuries · Chua AW, ..., Phan TT (4/6)
Papers · Keloids & scars · In vitro

Human skin keloid fibroblasts display bioenergetics of cancer cells.

The Journal of investigative dermatology · Vincent AS, ..., Phan TT (2/6)
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord (machine-translated)

KR20070053255A · KR · Application · Granted (status not shown)
Patents · Family F02

Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom

WO2007046775A1 · WO · Application · PCT phase ended
Patents · Family F01

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

WO2006019357A1 · WO · Application · PCT phase ended
Papers · Keloids & scars · In vitro

Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration.

Oncogene · Lim CP, ..., Phan TT (2/4)
Papers · Keloids & scars · In vitro

Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.

The Journal of pathology · Phan TT (first), ... (8 authors)
Papers · Keloids & scars · In vitro

Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars.

The Journal of trauma · Phan TT (first), ... (6 authors)
Papers · Keloids & scars · In vitro

Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro.

American journal of physiology. Cell physiology · Phan TT (first), ... (7 authors)
Papers · Keloids & scars · In vitro

Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and extracellular matrix production in keloids.

The Journal of biological chemistry · Lim IJ, ..., Phan TT (2/9)
Papers · Keloids & scars · Review

From scarless fetal wounds to keloids: molecular studies in wound healing.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · Yang GP, ..., Phan TT (3/5)
Papers · Keloids & scars · In vitro

Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner.

American journal of physiology. Cell physiology · Lim IJ, ..., Phan TT (2/8)
Company

CellResearch Corporation founded in Singapore

Co-founded by Phan Toan Thang (Group CSO), Gavin Tan (Group CEO) and Ivor Lim (CMO).

Papers · Wound & burn healing · In vitro

Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing.

The Journal of trauma · Phan TT (first), ... (4 authors)
Papers · Wound & burn healing · In vitro

Effects of an aqueous extract from the leaves of Chromolaena odorata (Eupolin) on the proliferation of human keratinocytes and on their migration in an in vitro model of reepithelialization.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · Phan TT (first), ... (3 authors)

14 patent families

Patents grouped by shared priority

FamilyPrioritySubjectGranted / totalGranted in
F012004-08-16Isolation, culture and uses of epithelial and mesenchymal stem/progenitor cells from the umbilical cord amniotic membrane (root family)22 / 26AU, BR, CA, CN, EP, GB, HK, JP, KR, MY, NZ, RU, TW, US, ZA
F022005-10-21Uses of cord amniotic membrane stem cells and cells derived from them (skin equivalents, chondrocytes, insulin-producing cells, cosmetic uses)8 / 10CN, EP, HK, US
F032015-12-14Generating transgene-carrying stem cells (with SingHealth)0 / 1-
F042016-10-05Isolating cord lining MSCs with a defined culture medium; high-purity population (CD73, CD90, CD105 at 97% or more)19 / 23AU, BR, CN, EP, HK, IL, JP, KR, MY, NZ, SA, TW, US, ZA
F052018-04-06Transgene-carrying cells from high-purity cord lining MSCs0 / 1-
F062018-04-09Transport solution (e.g. Trolox) for shipping MSCs and applying them to wounds (with the University of Colorado)5 / 6AU, JP, US
F072018-04-09Cell culture medium for shipping MSCs and applying them to wounds0 / 1-
F082018-04-12Culture conditions that induce or improve the wound-healing properties of MSCs7 / 10AU, CN, JP, TW, US, ZA
F092019-10-08Storage and transport formulation for MSCs (with the University of Colorado)3 / 6AU, CN, JP
F102019-10-08Potency assay for the wound-healing activity of MSCs4 / 6CN, JP, US, ZA
F112020-07-20iPS cells derived from cord lining stem cells (with SingHealth)1 / 3JP
F122022-01-27Differentiating iPS cells into retinal pigment epithelium (with A*STAR and SingHealth)0 / 2-
F132022-11-17Cord MSC conditioned medium (secretome) for hair growth and regeneration0 / 5-
F142022-12-09Cord lining MSC conditioned medium (secretome) for healing damaged skin and preventing recurrence0 / 5-

How to read this

Research results are not program outcomes

The papers and trials here describe the cells, conditions and subjects each study covered. They do not describe outcomes of using the Cellumium network or any partner program.

Mostly lab and animal studies

Of the 37 papers listed, 2 involve human participants. Each item states its study type.

Trials are at phase 1 safety

The US phase 1 study (9 completers) was a small uncontrolled safety study. The FDA IND and the UK MHRA designation are development-stage steps, not product approvals.

Interests are disclosed

Papers on CRC products with CRC-affiliated authors are marked with a conflict of interest note. Patent status (active or expired) follows Google Patents.

This page lists public records and makes no medical efficacy claims. It is not medical advice or a diagnosis.